| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Iovance Biotherapeutics, Inc. (IOVA) has 12 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. IOVA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 235.0K | $850.7K | - | |
| Dir | 135.1K | $489.0K | - | |
| Other | 132.2K | $478.6K | - | |
| CFO | 132.2K | $478.6K | - | |
| Other | 117.5K | $425.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Rothbaum Wayne P.60 | Director | Buy | 10,000,000 | $6.50 | $65,000,000.00 | +124.0% | +4.1% | -8.5% | |
| Nov 29, 2022 | McPeak Merrill A55 | Director | Buy | 10,000 | $6.31 | $63,100.00 | +4.4% | +16.8% | -7.5% | |
| Nov 28, 2022 | Vogt Frederick G59 | Interim CEO &General Counsel | Buy | 1,000 | $5.98 | $5,980.00 | +100.0% | +20.5% | -6.4% | |
| Nov 28, 2022 | McPeak Merrill A55 | Director | Buy | 10,000 | $6.18 | $61,800.00 | +4.6% | +20.5% | -6.4% | |
| Nov 23, 2022 | Dukes Iain D. | Director | Buy | 10,000 | $6.10 | $61,000.00 | +83.3% | +13.0% | -6.9% | |
| Jun 1, 2022 | Vogt Frederick G59 | Interim CEO &General Counsel | Buy | 1,000 | $6.44 | $6,440.00 | New | +63.8% | +36.8% | |
| Jun 1, 2022 | Rothbaum Wayne P.60 | Director | Buy | 1,000,000 | $6.60 | $6,600,050.00 | +6.8% | +63.8% | +36.8% | |
| May 31, 2022 | Weiser Michael | Director | Buy | 10,000 | $6.80 | $67,978.13 | +4.8% | +58.5% | +29.5% | |
| May 31, 2022 | Maynard Ryan D75 | Director | Buy | 7,500 | $6.75 | $50,587.50 | New | +58.5% | +29.5% | |
| May 31, 2022 | McPeak Merrill A55 | Director | Buy | 20,000 | $6.82 | $136,400.00 | +9.1% | +58.5% | +29.5% |